Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Other Operating Expenses (2022)

Eton Pharmaceuticals (ETON) has disclosed Other Operating Expenses for 1 consecutive years, with $1.1 million as the latest value for Q1 2022.

  • Quarterly Other Operating Expenses changed N/A to $1.1 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2022, changed N/A year-over-year, with the annual reading at -$6.6 million for FY2024, 308.81% down from the prior year.
  • Other Operating Expenses hit $1.1 million in Q1 2022 for Eton Pharmaceuticals.
  • In the past five years, Other Operating Expenses ranged from a high of $1.1 million in Q1 2022 to a low of $1.1 million in Q1 2022.